|
English
|
正體中文
|
简体中文
|
2815035
|
|
???header.visitor??? :
27386413
???header.onlineuser??? :
680
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"cross a"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立成功大學 |
2006-10 |
Entecavir (ETV) treatment through 96 weeks results in substantial virologic and biochemical improvement and HBeAg seroconversion in HBeAg(+) chronic hepatitis B (CHB) patients (study ETV-022)
|
Sollano, J.; De Man, R. A.; Mutimer, D.; Gish, R. G.; Chang, Ting-Tsung; Zhu, J.; Cross, A.; Brett-Smith, H. |
| 國立成功大學 |
2006-07 |
Entecavir (ETV) treatment through 96 weeks results in substantial virologic and biochemical improvement and HBeAg seroconversion in HBeAg(+) chronic hepatitis B (CHB) patients (study ETV-022)
|
De Man, R. A.; Mutimer, D.; Gish, R.; Chang, Ting-Tsung; Zhu, J.; Cross, A.; Brett-Smith, H. |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
